<DOC>
	<DOCNO>NCT00807261</DOCNO>
	<brief_summary>To determine activity weekly Docetaxel Gemcitabine patient advance soft tissue sarcoma previously treat anthracycline and/or ifosfamide 1 . Primary endpoint : response rate 2 . Secondary endpoint : progress-free survival , overall survival , safety</brief_summary>
	<brief_title>Weekly Docetaxel Fixed-Dose Rate Gemcitabine Combination Chemotherapy</brief_title>
	<detailed_description />
	<mesh_term>Sarcoma</mesh_term>
	<mesh_term>Gemcitabine</mesh_term>
	<mesh_term>Docetaxel</mesh_term>
	<criteria>Histologically confirm recurrent metastatic , unresectable soft tissue sarcoma bone sarcoma exception certain histopathologic subtypes sarcomas recognize expert derive benefit conventional chemotherapy ( e.g. , alveolar soft part sarcoma , clear cell sarcoma , chondrosarcoma , chordoma , desmoid tumor ) Bone sarcoma patient must visceral metastatic disease ( e.g. , metastatic lung liver ) Patients previously treat anthracycline and/or ifosfamide contain chemotherapy , firstline chemotherapy metastatic disease , adjuvant therapy Patients may 2 prior chemotherapy within 4 week start study treatment unidimensional measurable lesion Age ≥ 16 year Life expectancy 3 month ECOG performance status ≤ 2 Adequate bone marrow function ( ANC≥1,500/mm3 , platelet count ≥100,000/mm3 ) Adequate kidney function ( serum creatinine ≤ 1.5 mg/dL ) Adequate liver function ( bilirubin ≤ 2 mg/dl transaminase level ≤ 3 time upper normal limit , &lt; 5 time patient liver metastasis , serum alkaline phosphatase &lt; 2.5 time upper normal limit , &lt; 5 time liver metastasis present &lt; 10 time bone metastasis present ) . Adequate cardiac function ( Ejection fraction ≥ 50 % echoCG MUGA scan ) All patient fully informed nature purpose study give inform consent start treatment . Pregnant lactating patient Patients resectable lung metastasis Presence history CNS metastasis Prior history cancer within past 5 year , asides basal cell squamous cell carcinoma skin , carcinoma situ uterine cervix Any preexist medical condition sufficient severity prevent full compliance study .</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2008</verification_date>
</DOC>